Quest Diagnostics Inc vs Roundhill Russell 2000 0DTE Covered Call Strat ETF — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Roundhill Russell 2000 0DTE Covered Call Strat ETF trades at $29. The key difference: Quest Diagnostics Inc pays a 1.45% dividend while Roundhill Russell 2000 0DTE Covered Call Strat ETF pays none, and Quest Diagnostics Inc is trading nearer its 52-week high, Roundhill Russell 2000 0DTE Covered Call Strat ETF nearer its low. Which is the better fit depends on your goals.
| DGX | RDTE | |
|---|---|---|
Market Cap | $26.21B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $238.50 | $34.20 |
52-Week Low | $173.49 | $26.40 |
Enterprise Value | $31.97B | — |
Dividend Yield | 1.45% | — |
Trailing returns across standard periods
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →RDTE is an actively managed ETF that seeks to generate income through a covered call strategy on the Russell 2000 Index. The fund primarily holds a portfolio of short-term U.S. government securities and sells 0-DTE (zero days to expiration) index call options on the Russell 2000. This highly tactical strategy aims to maximize premium capture by exploiting the high time decay of options that are expiring on the same day, which provides enhanced income but also exposes the fund to significant volatility and risks associated with daily options settlement.
Read more on RDTE →